Latest News  

Intensive, Personalized Learning

During the 2019 ACR/ARP Annual Meeting, the new Meet the Professor Workshops and sessions will feature hands-on training on state-of-the-art topics… [Read More]

FDA approves the Biosimilar Hadlima (Adalimumab-bwwd)

Hadlima (adalimumab-bwwd), which is biosimilar to adalimumab, is now FDA approved to treat multiple autoimmune diseases… [Read More]

Catch Your Breath: Insights into ILD in RA Patients

Detecting interstitial lung disease in RA patients can be challenging. But evaluating risk factors and the use of imaging can help clinicians identify and manage this condition in patients… [Read More]

Patients & Physicians Unite for Arthritis Advocacy

Nearly 120 ACR/ARP member advocates and rheumatology patients were on Capitol Hill this week fighting for rheumatology as part of the ACR’s Advocates for Arthritis conference. [Read More]

High-Dose Teriparatide with Denosumab Gives Bigger BMD Boost

NEW YORK (Reuters Health)—Adding high-dose teriparatide to denosumab therapy leads to substantially greater increases in bone-mineral density (BMD) than combination therapy with low-dose teriparatide, a… [Read More]

No Gain with Pain: Exercise & Physical Function in Patients with Rheumatic Disease

Pain can deter patients with rheumatic disease from engaging in physical activity. But the latest research shows exercise helps reduce pain, & other influences may also affect patients’ activity levels, particularly after surgery… [Read More]

View More Latest News »